HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity.

Cited by (702)

Items 101–200 of 702

  1. Harnessing CD8+ T Cells Under HIV Antiretroviral Therapy
    Joanna A Warren, Genevieve Clutton, Nilu P Goonetilleke · 2019 · Frontiers in Immunology
  2. Vitamin D deficiency in HIV infection: an underestimated and undertreated epidemic.
    Marilia Rita Pinzone, Michelino Di Rosa, Mariano Malaguarnera, Giordano Madeddu, Emanuele Focà, Giancarlo Ceccarelli, Gabriella d’Ettorre, Vullo, Rossella Fisichella, Bruno Santi Cacopardo et al. · 2013 · PubMed
  3. Incidence and Impact on Mortality of Severe Neurocognitive Disorders in Persons With and Without HIV Infection: A Danish Nationwide Cohort Study
    François-Xavier Lescure, Lars Haukali Omland, Frederik Neess Engsig, Casper Roed, Jan Gerstoft, Gilles Pialoux, Gitte Kronborg, Carsten Schade Larsen, Niels Obel · 2010 · Clinical Infectious Diseases
  4. HIV and Premature Aging: A Field Still in Its Infancy
    Jeffrey N. Martin, Paul A. Volberding · 2010 · Annals of Internal Medicine
  5. Neurocognitive Effects of HIV, Hepatitis C, and Substance Use History
    Kathryn N. Devlin, Assawin Gongvatana, Uraina S. Clark, Jesse D. Chasman, Michelle L. Westbrook, Karen T. Tashima, BRADFORD A. NAVIA, Ronald A. Cohen · 2011 · Journal of the International Neuropsychological Society
  6. Human Immunodeficiency Virus (HIV) Latency: The Major Hurdle in HIV Eradication
    Mudit Tyagi, Michael Bukrinsky · 2012 · Molecular Medicine
  7. Absolute Leukocyte Telomere Length in HIV-Infected and Uninfected Individuals: Evidence of Accelerated Cell Senescence in HIV-Associated Chronic Obstructive Pulmonary Disease
    Joseph C. Y. Liu, Janice M. Leung, David A. Ngan, Negar F. Nashta, Silvia A. Guillemi, Marianne Harris, Viviane Dias Lima, Soo‐Jung Um, Yuexin Li, Sheena Tam et al. · 2015 · PLoS ONE
  8. Noninfectious Comorbidity in the African Cohort Study
    Julie A. Ake, Christina S. Polyak, Trevor A. Crowell, Francis Kiweewa, Michael Semwogerere, Lucas Maganga, Emmanuel Bahemana, Jonah K. Maswai, Rither Langat, John Owuoth et al. · 2018 · Clinical Infectious Diseases
  9. The Immunologic Effects of Mesalamine in Treated HIV-Infected Individuals with Incomplete CD4+ T Cell Recovery: A Randomized Crossover Trial
    Ma Somsouk, Richard M. Dunham, Michelle L. Cohen, Rebecca G. Albright, Mohamed Abdel‐Mohsen, Teri J. Liegler, Jeffrey D. Lifson, Michael Piatak, Robert J. Gorelick, Yong Huang et al. · 2014 · PLoS ONE
  10. Progressive Proximal-to-Distal Reduction in Expression of the Tight Junction Complex in Colonic Epithelium of Virally-Suppressed HIV+ Individuals
    Charlotte Y. Chung, Stephanie Leigh Alden, Nicholas Funderburg, Pingfu Fu, Alan D. Levine · 2014 · PLoS Pathogens
  11. A Review on Quinoline Derived Scaffolds as Anti-HIV Agents
    Nisha Chokkar, Sourav Kalra, Monika Chauhan, Raj Kumar · 2018 · Mini-Reviews in Medicinal Chemistry
  12. Highly Significant Antiviral Activity of HIV-1 LTR-Specific Tre-Recombinase in Humanized Mice
    Ilona Hauber, Helga Hofmann-Sieber, Jan Chemnitz, Danilo Dubrau, Janet Chusainow, Rolf Stucka, Philip Hartjen, Axel Schambach, Patrick Ziegler, Karl Hackmann et al. · 2013 · PLoS Pathogens
  13. Risks of cardiovascular or central nervous system adverse events and immune reconstitution inflammatory syndrome, for dolutegravir versus other antiretrovirals
    Andrew Martin Hill, Nikkita Mitchell, Sophie L. Hughes, Anton Pozniak · 2017 · Current Opinion in HIV and AIDS
  14. Subclinical Atherosclerosis and Markers of Immune Activation in HIV-Infected Children and Adolescents
    Talía Sainz, María Álvarez-Fuente, María Luisa Navarro, Laura Díaz, Pablo Rojo, Daniel Blázquez‐Gamero, María Isabel de José, José Tomás Ramos, Sergio Serrano Villar, Jorge Martínez et al. · 2013 · JAIDS Journal of Acquired Immune Deficiency Syndromes
  15. Impact of early cART in the gut during acute HIV infection
    Claire Deléage, Alexandra Schuetz, W. Gregory Alvord, Leslie Johnston, Xingpei Hao, David R. Morcock, Rungsun Rerknimitr, James L. K. Fletcher, Suwanna Puttamaswin, Nittaya Phanuphak et al. · 2016 · JCI Insight
  16. Cannabinoids and inflammation
    Cecilia Theresa Costiniuk, Mohammad-Ali Jenabian · 2019 · AIDS
  17. The HIV care cascade: Japanese perspectives
    Aikichi Iwamoto, Rikizo Taira, Yoshiyuki Yokomaku, Tomohiko Koibuchi, Mahbubur Rahman, Yoko Izumi, Kenji Tadokoro · 2017 · PLoS ONE
  18. Excess Clinical Comorbidity Among HIV-Infected Patients Accessing Primary Care in US Community Health Centers
    Kenneth Hugh Mayer, Stephanie S. Loo, Phillip M. Crawford, Heidi M. Crane, Michael C. Leo, Paul W. DenOuden, Magda Houlberg, Mark A. Schmidt, Thu Quach, Sebastian Ruhs et al. · 2017 · Public Health Reports
  19. Characterization of Comorbidities Limiting the Recruitment of Patients in Early Phase Clinical Trials
    Narjust Duma, Sejal M. Kothadia, Tariq U. Azam, Siddhartha Yadav, Jonas Paludo, Jesus Vera Aguilera, Miguel González Vélez, Thorvardur Ragnar Halfdanarson, Julian R. Molina, Joleen Marie Hubbard et al. · 2018 · The Oncologist
  20. Topographies of Cortical and Subcortical Volume Loss in HIV and Aging in the cART Era
    Anika Guha, Matthew R. Brier, Mario Ortega, Elizabeth Terry Westerhaus, Brittany Nelson, Beau M. Ances · 2016 · JAIDS Journal of Acquired Immune Deficiency Syndromes
  21. What influences quality of life in older people living with HIV?
    On behalf of the HALL (HIV and Later Life) Team, José Catalán, Veronica Tuffrey, Damien Ridge, Dana Rosenfeld · 2017 · AIDS Research and Therapy
  22. Risk, predictors, and mortality associated with non-AIDS events in newly diagnosed HIV-infected patients
    Mar Masiá, Sergio Padilla, Débora Álvarez-del Arco, Juan Carlos López, Ignacio de los Santos, Vincent Soriano, José Hernández‐Quero, Jesús Santos, Cristina Tural, Julia del Amo et al. · 2012 · AIDS
  23. Association between peripheral T-Lymphocyte activation and impaired bone mineral density in HIV-infected patients
    Lidia Gazzola, Giusi Maria Bellistrì, Camilla Tincati, Valentina Ierardi, Alessia Savoldi, Angelo Del Sole, Luca Tagliabue, Antonella d’Arminio Monforte, Giulia Carla Marchetti · 2013 · Journal of Translational Medicine
  24. Association of immune-activation and senescence markers with non-AIDS-defining comorbidities in HIV-suppressed patients
    P. Duffau, Linda Wittkop, Estibaliz Lazaro, Fabien le Marec, Céline Cognet, Patrick Blanco, Jean‐François Moreau, Frédéric‐Antoine Dauchy, Charles Cazanave, M.A. Vandenhende et al. · 2015 · AIDS
  25. Projected Lifetime Healthcare Costs Associated with HIV Infection
    Fumiyo Nakagawa, Alec H. Miners, Colette J Smith, Ruth Simmons, Rebecca K. Lodwick, Valentina Cambiano, Jens Dilling Lundgren, Valérie Delpech, Andrew N. Phillips · 2015 · PLoS ONE
  26. ‘We never expected this to happen’: narratives of ageing with HIV among gay men living in London, UK
    Gareth J. Owen, José Catalán · 2011 · Culture Health & Sexuality
  27. Coronary Endothelial Dysfunction Is Associated With Elevated Serum PCSK9 Levels in People With HIV Independent of Low‐Density Lipoprotein Cholesterol
    Thorsten Martin Leucker, Robert George Weiss, Michael Schär, Gabriele Bonanno, Lena M. Mathews, Steven Richard Jones, Todd Tarquin Brown, Richard D. Moore, Yohannes Afework, Gary Gerstenblith et al. · 2018 · Journal of the American Heart Association
  28. Prodrugs of PKC modulators show enhanced HIV latency reversal and an expanded therapeutic window
    Jack L. Sloane, Nancy L. Benner, Katherine N. Keenan, Xiaoyu Zang, Mohamed S. A. Soliman, Xiaomeng Wu, Melanie Dimapasoc, Tae‐Wook Chun, Matthew D. Marsden, Jerome A. Zack et al. · 2020 · Proceedings of the National Academy of Sciences
  29. Objective impairments of gait and balance in adults living with HIV-1 infection: a systematic review and meta-analysis of observational studies
    Karina Berner, Linzette Deidré Morris, Jochen Baumeister, Quinette Abegail Louw · 2017 · BMC Musculoskeletal Disorders
  30. Chronicity, crisis, and the ‘end of AIDS’
    Thurka Sangaramoorthy · 2018 · Global Public Health
  31. High Prevalence of Sarcopenia in HIV-Infected Individuals
    Patricia Echeverría, Anna Bonjoch, Jordi Puig, Carla Estany, Arelly Ornelas, Bonaventura Clotet, Eugènia Negredo · 2018 · BioMed Research International
  32. Baseline Kidney Function as Predictor of Mortality and Kidney Disease Progression in HIV-Positive Patients
    Fowzia Ibrahim, Lisa Hamzah, Rachael Jones, Dorothea Nitsch, Caroline Anne Sabin, Frank A. Post · 2012 · American Journal of Kidney Diseases
  33. Achieving a cure for HIV infection: do we have reasons to be optimistic?
    Valentin Le Douce, Andrea Janossy, Houda Hallay, Sultan Ali, Raphaël Riclet, Olivier Rohr, Christian Schwartz · 2012 · Journal of Antimicrobial Chemotherapy
  34. The paradox of the immune response in HIV infection: When inflammation becomes harmful
    Hayley Ipp, Annalise E. Zemlin · 2012 · Clinica Chimica Acta
  35. Increased prevalence and severity of radiographic hand osteoarthritis in patients with HIV-1 infection associated with metabolic syndrome: data from the cross-sectional METAFIB-OA study
    A.-L. Tomi, Jérémie Sellam, Karine Lacombe, Soraya Fellahi, Manuela Sébire, Caroline Rey-Jouvin, Anne Miquel, Jean‐Philippe Bastard, E. Maheu, Ida Kristin Haugen et al. · 2016 · Annals of the Rheumatic Diseases
  36. Non-AIDS-defining events among HIV-1-infected adults receiving combination antiretroviral therapy in resource-replete versus resource-limited urban setting
    C. William Wester, John Robert Koethe, Bryan E. Shepherd, Samuel E. Stinnette, Peter F. Rebeiro, Aaron M. Kipp, Hwanhee Hong, Hermann Bussmann, Tendani Gaolathe, Catherine C. McGowan et al. · 2011 · AIDS
  37. Regional Differences in AIDS and Non-AIDS Related Mortality in HIV-Positive Individuals across Europe and Argentina: The EuroSIDA Study
    Joanne Reekie, Justyna Dominika Kowalska, Igor Karpov, Jürgen Kurt Rockstroh, Anders Karlsson, Aza Gasanovna Rakhmanova, Andrzéj Horban, Ole Kirk, Jens Dilling Lundgren, Amanda Mocroft et al. · 2012 · PLoS ONE
  38. Erectile Dysfunction Is More Common in Young to Middle‐Aged HIV‐Infected Men than in HIV‐Uninfected Men
    Stefano Zona, Giovanni Guaraldi, Kety Luzi, Mattia Beggi, Daniele Santi, Chiara Stentarelli, Bruno Madeo, Vincenzo Rochira · 2012 · The Journal of Sexual Medicine
  39. Diabetes and Hypertension among Patients Receiving Antiretroviral Treatment Since 1998 in Senegal: Prevalence and Associated Factors
    Assane Diouf, Amandine Cournil, K. Bâ-Fall, Ndèye Fatou Ngom-Guèye, Sabrina Eymard‐Duvernay, Ibrahima Ndiaye, Gilbert Batista, P.M. Gueye, Pape Samba Ba, Bernard Taverne et al. · 2012 · ISRN AIDS
  40. Increased non‐ AIDS mortality among persons with AIDS ‐defining events after antiretroviral therapy initiation
    April Christine Pettit, Mark J Giganti, Suzanne Marie Ingle, Margaret May, Bryan E. Shepherd, Michael John Gill, Gerd Fätkenheuer, Sophie Abgrall, Michael S. Saag, Julia del Amo et al. · 2018 · Journal of the International AIDS Society
  41. HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial
    Fabrizio Ensoli, Aurelio Cafaro, Anna Casabianca, Antonella Tripiciano, Stefania Bellino, Olimpia Longo, Vittorio Francavilla, Orietta Picconi, Cecilia Sgadari, Sonia Moretti et al. · 2015 · Retrovirology
  42. Cost of noninfectious comorbidities in patients with HIV
    Giovanni Guaraldi, Palella, Stefano Zona, Menozzi, Carli, Bagni, Berti, Elisa Rossi, Orlando, Zoboli · 2013 · ClinicoEconomics and Outcomes Research
  43. Depression Correlates with Increased Plasma Levels of Inflammatory Cytokines and a Dysregulated Oxidant/Antioxidant Balance in HIV-1-Infected Subjects Undergoing Antiretroviral Therapy
    Yainyrette Rivera Yashira García · 2014 · Journal of Clinical & Cellular Immunology
  44. Low testosterone is associated with poor health status in men with human immunodeficiency virus infection: a retrospective study
    Vincenzo Rochira, Chiara Diazzi, Daniele Santi, Giulia Brigante, Anna Ansaloni, Maria Chiara Decaroli, Sara De Vincentis, Chiara Stentarelli, Stefano Zona, Giovanni Guaraldi · 2015 · Andrology
  45. Infection‐related and ‐unrelated malignancies, HIV and the aging population
    Leah C. Shepherd, Álvaro Humberto Borges, Bruno Ledergerber, Peré Domingo, Antonella Castagna, Jürgen Kurt Rockstroh, Brygida Knysz, Janez Tomažič, Igor Karpov, Ole Kirk et al. · 2016 · HIV Medicine
  46. The role of tenofovir alafenamide in future HIV management
    Antonio Antela, Carlos Aguíar, Juliet Elizabeth Compston, BM Hendry, Marta Boffito, Patrick W. G. Mallon, Valérie Pourcher, Giovanni Di Perri · 2016 · HIV Medicine
  47. Chronic health conditions in Medicare beneficiaries 65 years and older with HIV infection
    Eleanor E. Friedman, Wayne A. Duffus · 2016 · AIDS
  48. The Hidden Burden of Fractures in People Living With HIV
    Melissa Orlandin Premaor, Juliet Elizabeth Compston · 2018 · JBMR Plus
  49. Comorbidities and the use of comedications in people living with HIV on antiretroviral therapy in Japan: a cross-sectional study using a hospital claims database
    Daniel J. Ruzicka, Kentaro Imai, Kenichi Takahashi, Toshio Naito · 2018 · BMJ Open
  50. Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virus
    Juan Antonio Moreno, Luis M. Beltrán, Alfonso Rubio‐Navarro, Juan García Puig, Juan Manuel Amaro-Villalobos, Jesús Egido · 2015 · Vascular Health and Risk Management
  51. Severe bacterial non-aids infections in HIV-positive persons: Incidence rates and risk factors
    Ole Schmeltz Søgaard, Joanne Reekie, Matti A. Ristola, Djordje Jevtović, Igor Karpov, Marek Beniowski, S. Servitskiy, Peré Domingo, Peter Reiss, Amanda Mocroft et al. · 2013 · Journal of Infection
  52. The eye as a model of ageing in translational research – Molecular, epigenetic and clinical aspects
    Sophia Pathai, Paul G. Shiels, Stephen D Lawn, Colin Cook, Clare Elizabeth Gilbert · 2012 · Ageing Research Reviews
  53. A CRISPR/Cas9 screen identifies the histone demethylase MINA53 as a novel HIV-1 latency-promoting gene (LPG)
    Huachao Huang, Weili Kong, Maxime Junior Jean, Guillaume N. Fiches, Dawei Zhou, Tsuyoshi Hayashi, Jianwen Que, Netty G. Santoso, Jian Kang Zhu · 2019 · Nucleic Acids Research
  54. The Ryan White HIV/AIDS Program in the Age of Health Care Reform
    Seán Cahill, Kenneth Hugh Mayer, Stephen Boswell · 2015 · American Journal of Public Health
  55. Sirtuin-1 and HIV-1: An Overview
    Marilia Rita Pinzone, Bruno Santi Cacopardo, Fabrizio Condorelli, Michelino Di Rosa, Giuseppe Nunnari · 2013 · Current Drug Targets
  56. Taming HIV-Related Inflammation with Physical Activity: A Matter of Timing
    Gabriella d’Ettorre, Giancarlo Ceccarelli, Noemi Giustini, Claudio Maria Mastroianni, Guido Silvestri, Vincenzo Vullo · 2014 · AIDS Research and Human Retroviruses
  57. Association between the use of protease inhibitors in highly active antiretroviral therapy and incidence of diabetes mellitus and/or metabolic syndrome in HIV-infected patients: A systematic review and meta-analysis
    Jose Echecopar-Sabogal, Lorenzo D’Angelo-Piaggio, Diego M. Chanamé-Baca, César Ugarte‐Gil · 2017 · International Journal of STD & AIDS
  58. The current understanding of overlap between characteristics of HIV-associated neurocognitive disorders and Alzheimer’s disease
    Leah H. Rubin, Erin E. Sundermann, David J. Moore · 2019 · Journal of NeuroVirology
  59. Lessons learned from the first wave of aging with HIV
    Amy C. Justice, Ronald Scott Braithwaite · 2012 · AIDS
  60. Greater burden of chronic comorbidities and co-medications among people living with HIV versus people without HIV in Japan: A hospital claims database study
    Daniel J. Ruzicka, Kentaro Imai, Kenichi Takahashi, Toshio Naito · 2018 · Journal of Infection and Chemotherapy
  61. Eliminating the latent HIV reservoir by reactivation strategies: Advancing to clinical trials
    Thomas A. Rasmussen, Martin Tolstrup, Anni Assing Winckelmann, Lars Jørgen Østergaard, Ole Schmeltz Søgaard · 2013 · Human Vaccines & Immunotherapeutics
  62. Strong Impact of Smoking on Multimorbidity and Cardiovascular Risk Among Human Immunodeficiency Virus-Infected Individuals in Comparison With the General Population
    Barbara Katharina Hasse, PE Tarr, Pedro Marques-Vidal, Gérard Waeber, Martin Preisig, Vincent Mooser, Fabio Valeri, Sima Djalali, Andri Rauch, Enos Bernasconi et al. · 2015 · Open Forum Infectious Diseases
  63. Incidence of Non-AIDS-Defining Cancer in Antiretroviral Treatment-Naïve Subjects after Antiretroviral Treatment Initiation: An ACTG Longitudinal Linked Randomized Trials Analysis
    Supriya Krishnan, Jeffrey T. Schouten, Denise L. Jacobson, Constance Ann Benson, Ann C. Collier, Susan L. Koletar, Jorge Santana, Fred R. Sattler, Ronald T. Mitsuyasu, for the ACTG-ALLRT Protocol Team · 2011 · Oncology
  64. The Immunomodulatory Nutritional Intervention NR100157 Reduced CD4+ T-Cell Decline and Immune Activation: A 1-Year Multicenter Randomized Controlled Double-Blind Trial in HIV-Infected Persons Not Receiving Antiretroviral Therapy (The BITE Study)
    Pedro Enrique Cahn, Kiat Ruxrungtham, Brian Gazzard, Ricardo Sobhie Diaz, Andrea Gori, Donald P. Kotler, Aldwin J. M. Vriesema, Niki Georgiou, Johan Garssen, Mario Clerici et al. · 2013 · Clinical Infectious Diseases
  65. Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: a cohort study
    ‡ · 2011 · The Lancet Infectious Diseases
  66. Immune restoration in HIV-1-infected patients after 12 years of antiretroviral therapy: a real-world observational study
    Jiaye Liu, Lifeng Wang, Yuying Hou, Yan Zhao, Zhihui Dou, Ye Ma, Dawei Zhang, Yasong Wu, Decai Zhao, Zhongfu Liu et al. · 2020 · Emerging Microbes & Infections
  67. HIV/AIDS, comorbidity, and alcohol: can we make a difference?
    Amy C. Justice, Lynn E. Sullivan, David A. Fiellin · 2010 · Europe PMC (PubMed Central)
  68. Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028—study protocol for a pilot randomised trial to assess safety, tolerability and effect on immune activation
    Cecilia Theresa Costiniuk, Zahra Saneei, Jean‐Pierre Routy, Shari L. Margolese, Enrico Mandarino, Joel Singer, Bertrand Lebouché, Joseph Cox, Jason Szabo, Marie‐Josée Brouillette et al. · 2019 · BMJ Open
  69. Accelerated aging in perinatally HIV-infected children: clinical manifestations and pathogenetic mechanisms
    Chiappini, Elena, Bianconi, Martina, Dalzini, Annalisa, Petrara, Maria Raffaella, Galli, Luisa, Giaquinto, Carlo, De Rossi, Anita · 2018 · Aging
  70. Managing drug interactions in HIV-infected adults with comorbid illness
    Christine A. Hughes, Alice Lin-In Tseng, Ryan D. Cooper · 2014 · Canadian Medical Association Journal
  71. Persisting Inflammation and Chronic Immune Activation but Intact Cognitive Function in HIV-Infected Patients After Long-Term Treatment With Combination Antiretroviral Therapy
    Karin Kaereby Pedersen, Maria Pedersen, Julie Christine Gaardbo, Andreas Ronit, Hans Jakob Hartling, Helle Brüünsgaard, Jan Gerstoft, Henrik Ullum, Susanne Dam Nielsen · 2013 · JAIDS Journal of Acquired Immune Deficiency Syndromes
  72. Using Community Health Workers to Improve Clinical Outcomes Among People Living with HIV: A Randomized Controlled Trial
    Sonjia Kenya, Jamal Jones, Kristopher L. Arheart, Erin K. Kobetz, Natasha M. Chida, Shelly Baer, Alexis R. Powell, Stephen N. Symes, Tai Hunte, Anne Kress Monroe et al. · 2013 · AIDS and Behavior
  73. Changes in the prevalence of lipodystrophy, metabolic syndrome and cardiovascular disease risk in HIV-infected men*
    Julia Price, Jennifer Hoy, Emma Jean Ridley, Ibolya B. Nyulasi, Eldho Mathew Paul, Ian John Woolley · 2015 · Sexual Health
  74. Finding a cure for HIV: will it ever be achievable?
    Sharon R. Lewin, Vanessa A. Evans, Julian H. Elliott, Bruno Spire, Nicolas Chomont · 2011 · Journal of the International AIDS Society
  75. Neutrophils in antiretroviral therapy–controlled HIV demonstrate hyperactivation associated with a specific IL-17/IL-22 environment
    L. Campillo-Gimenez, Sarah Casulli, Yasmine Dudoit, Sophie Seang, Guislaine Carcelain, Sidonie Lambert-Niclot, Victor Appay, Brigitte Autran, Roland Tubiana, Carole Elbim · 2014 · Journal of Allergy and Clinical Immunology
  76. Frailty, markers of immune activation and oxidative stress in HIV infected elderly
    Susana Álvarez, Fátima Brañas, Matilde Sánchez‐Conde, Santiago Moreno, Juan Carlos López Bernaldo de Quirós, María Ángeles Muñoz‐Fernández · 2020 · PLoS ONE
  77. Increased costs of HIV care associated with aging in an HIV ‐infected population
    Hartmut B. Krentz, Michael John Gill · 2014 · HIV Medicine
  78. Causes of death in HIV-infected patients from the Cologne–Bonn cohort
    Kathrin Ehren, Ch. Hertenstein, Tim Kümmerle, Jörg Janne Vehreschild, Julia Fischer, Daniel Gillor, Christoph Wyen, Clara Lehmann, Oliver A. Cornely, Norma Jung et al. · 2013 · Infection
  79. Thoracic Diseases Associated with HIV Infection in the Era of Antiretroviral Therapy: Clinical and Imaging Findings
    Shinn-Huey Shirley Chou, Somnath J. Prabhu, Kristina A. Crothers, Eric J. Stern, J. David Godwin, Sudhakar N. J. Pipavath · 2014 · Radiographics
  80. Cardiovascular Complications of HIV in Endemic Countries
    Matthew J. Feinstein, Milana Bogorodskaya, Gerald S. Bloomfield, Rajesh Vedanthan, Mark Jacob Siedner, Gene F. Kwan, Chris Todd Longenecker · 2016 · Current Cardiology Reports
  81. Terminal differentiation of T cells is strongly associated with CMV infection and increased in HIV-positive individuals on ART and lifestyle matched controls
    Thijs Booiman, Ferdinand W.N.M. Wit, Arginell F. Girigorie, Irma Maurer, Davide De Francesco, Caroline Anne Sabin, Agnes M. Harskamp, Maria Prins, Claudio Franceschi, Steven G. Deeks et al. · 2017 · PLoS ONE
  82. Curaxin CBL0100 Blocks HIV-1 Replication and Reactivation through Inhibition of Viral Transcriptional Elongation
    Maxime Junior Jean, Tsuyoshi Hayashi, Huachao Huang, Justin W Brennan, Sydney Simpson, Andrei A. Purmal, Katerina V. Gurova, Michael C. Keefer, James J. Kobie, Netty G. Santoso et al. · 2017 · Frontiers in Microbiology
  83. Cardiovascular risk factors in HIV infected individuals: Comparison with general adult control population in Greece
    Giota Touloumi, Natasa Kalpourtzi, Vasileios Papastamopoulos, Vasilios Paparizos, Georgios Adamis, Anastasia Antoniadou, Maria Chini, Argiro Karakosta, Konstantinos Makrilakis, Magda Gavana et al. · 2020 · PLoS ONE
  84. Inhibition of HIV-1 entry by the tricyclic coumarin GUT-70 through the modification of membrane fluidity
    Kouki Matsuda, Shin-ichiro Hattori, Ryusho Kariya, Yuji Komizu, Eriko Kudo, Hiroki Goto, Manabu Taura, Ryuichi Ueoka, Shinya H Kimura, Seiji Okada · 2015 · Biochemical and Biophysical Research Communications
  85. HIV and Vertebral Fractures: a Systematic Review and Metanalysis
    Thales A. S. H. Ilha, Fábio Vasconcellos Comim, Rafaela Martinez Copês, Juliet Elizabeth Compston, Melissa Orlandin Premaor · 2018 · Scientific Reports
  86. Monocytes Expand with Immune Dysregulation and Is Associated with Insulin Resistance in Older Individuals with Chronic HIV
    Cecilia M. Shikuma, Dominic Cheung Chow, Louie Mar A. Gangcuangco, Guangxiang Zhang, Sheila Marie Keating, Philip J. Norris, Todd B. Seto, Nisha I. Parikh, Kalpana J. Kallianpur, Beau K. Nakamoto et al. · 2014 · PLoS ONE
  87. Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements
    The antiretroviral therapy cohort collaboration (ART-CC) · 2009 · AIDS
  88. Noncommunicable Diseases Burden and Risk Factors in a Cohort of HIV+ Elderly Patients in Malawi
    Fausto Ciccacci, Victor Tamba Tolno, Anna Maria Doro Altan, Giuseppe Liotta, Stefano Orlando, Sandro Mancinelli, Leonardo Palombi, Maria Cristina Marazzi · 2019 · AIDS Research and Human Retroviruses
  89. Persistently Elevated Serum Interleukin-6 Predicts Mortality Among Adults Receiving Combination Antiretroviral Therapy in Botswana: Results from a Clinical Trial
    Bethan McDonald, Sikhulile M. Moyo, Lesego Gabaitiri, Simani Gaseitsiwe, Hermann Bussmann, John Robert Koethe, Rosemary Mubanga Musonda, Joseph M. Makhema, Vladimir Novitsky, Richard Marlink et al. · 2013 · AIDS Research and Human Retroviruses
  90. Markers of chronic obstructive pulmonary disease are associated with mortality in people living with HIV
    Matthew Triplette, Amy C. Justice, Engi Farouk Attia, Janet Tate, Sheldon T. Brown, Matthew Bidwell Goetz, Joon W. Kim, Maria C. Rodriguez‐Barradas, Guy W. Soo Hoo, Cherry Wongtrakool et al. · 2017 · AIDS
  91. Comorbidity and comedication burden among people living with HIV in the United States
    Misti L. Paudel, Girish Prajapati, Erin K. Buysman, Swarnali Goswami, Jianbin Mao, Kimberly McNiff, Princy N. Kumar · 2022 · Current Medical Research and Opinion
  92. Prevalence and characteristics of metabolic syndrome and its components among adults living with and without HIV in Nigeria: a single-center study
    Jibreel Jumare, Patrick Dakum, Nadia Adjoa Sam-Agudu, Peter T. N. Memiah, Rebecca G. Nowak, Florence O. Bada, Uzoamaka Oguama, George Odonye, Ruxton Adebiyi, Cristiana Cairo et al. · 2023 · BMC Endocrine Disorders
  93. Immunosenescence and aging in HIV
    Chris M. Tsoukas · 2014 · Current Opinion in HIV and AIDS
  94. Incidence of liver cirrhosis in HIV-infected patients with chronic hepatitis B or C in the era of highly active antiretroviral therapy
    Paula Tuma, J. Medraño, Salvador Resino, Eugenia Vispo, Antonio Madejón, Carlos Sánchez‐Piedra, Pablo Rivas, Pablo Labarga, Luz Martín‐Carbonero, Pablo Barreiro et al. · 2010 · Antiviral Therapy
  95. HIV, Sexual Health, and Psychosocial Issues Among Older Adults Living with HIV in North America
    David J. Brennan, Charles A. Emlet, Angela Eady · 2011 · Ageing International
  96. Increased Coronary Vessel Wall Thickness in HIV-Infected Young Adults
    Khaled Z. Abd‐Elmoniem, Aylin B. Unsal, Sarah Eshera, Jatin R. Matta, Nancy Muldoon, Dorothea McAreavey, Julia Purdy, Rohan Hazra, Colleen M. Hadigan, Ahmed M. Gharib · 2014 · Clinical Infectious Diseases
  97. What happens to cardiovascular system behind the undetectable level of HIV viremia?
    Gabriella d’Ettorre, Giancarlo Ceccarelli, Paolo Pavone, Pietro Vittozzi, Gabriella De Girolamo, Ivan Schietroma, Sara Serafino, Noemi Giustini, Vincenzo Vullo · 2016 · AIDS Research and Therapy
  98. Mortality and treatment response amongst HIV-infected patients 50 years and older accessing antiretroviral services in South Africa
    Halima Dawood, Razia Hassan-Moosa, Nonhlanhla Yende‐Zuma, Kogieleum Naidoo · 2018 · BMC Infectious Diseases
  99. A Randomized Controlled Trial of a Rapid Re-housing Intervention for Homeless Persons Living with HIV/AIDS: Impact on Housing and HIV Medical Outcomes
    Vivian L. Towe, Ellen Weiss Wiewel, Yaoyu Zhong, Sebastian Linnemayr, Rachel E. Johnson, John Rojas · 2019 · AIDS and Behavior
  100. Clinical consequences of asymptomatic cytomegalovirus in treated human immunodeficency virus infection
    Samuel R Schnittman, Peter W. Hunt · 2021 · Current Opinion in HIV and AIDS